Number of Cardiologists per Cardiovascular Beds and In-Hospital Mortality for Acute Heart Failure: A Nationwide Study in Japan.
Acute Disease
Adrenergic beta-Antagonists
/ therapeutic use
Aged
Aged, 80 and over
Angiotensin Receptor Antagonists
/ therapeutic use
Angiotensin-Converting Enzyme Inhibitors
/ therapeutic use
Cardiologists
/ statistics & numerical data
Coronary Care Units
/ statistics & numerical data
Female
Health Workforce
Heart Failure
/ drug therapy
Hospital Bed Capacity
/ statistics & numerical data
Hospital Mortality
Hospital Units
/ statistics & numerical data
Hospitals, Teaching
/ statistics & numerical data
Humans
Japan
/ epidemiology
Logistic Models
Male
Mineralocorticoid Receptor Antagonists
/ therapeutic use
Multilevel Analysis
Odds Ratio
Japanese Registry of All Cardiac and Vascular Diseases
cardiologist
database
heart failure
quality assessment
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
17 09 2019
17 09 2019
Historique:
entrez:
10
9
2019
pubmed:
10
9
2019
medline:
15
9
2020
Statut:
ppublish
Résumé
Background Little evidence is available about the number of cardiologists required for appropriate treatment of heart failure (HF). Our objective was to determine the association between the number of cardiologists per cardiology beds for treating patients with acute HF and in-hospital mortality. Methods and Results This was a cross-sectional study, and we used the Japanese Registry of All Cardiac and Vascular Diseases Diagnosis Procedure Combination discharge database. The data of patients with HF on emergency admission from April 1, 2012, to March 31, 2014, were extracted. The patients were categorized into 4 groups by the quartiles of the numbers of cardiologists per 50 cardiovascular beds (first group: median, 4.4 [interquartile range, 3.5-5.0]; second group: median, 6.7 [interquartile range, 6.5-7.5]; third group: median, 9.7 [interquartile range, 8.8-10.1]; and fourth group: median, 16.7 [interquartile range, 14.0-23.8]). Using multilevel mixed-effect logistics regression, we determined adjusted odds ratios for in-hospital mortality. We identified 154 290 patients with HF on emergency admissions. There were 29 626, 36 587, 46 451, and 41 626 patients in the first, second, third, and fourth groups, respectively. HF severity, on the basis of New York Heart Association classification, was similar in the 3 groups. Adjusted odds ratios (95% CIs) for in-hospital mortality were 0.92 (0.82-1.04; P=0.20), 0.82 (0.72-0.92; P<0.001), and 0.70 (0.61-0.80; P<0.001) for the second, third, and fourth groups, respectively. The proportion of medication used, including angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, β blockers, and mineralocorticoid receptor antagonists, was positively correlated to the number of cardiologists. Conclusions Patients hospitalized for HF in hospitals with larger numbers of cardiologists per cardiovascular beds had lower 30-day mortality.
Identifiants
pubmed: 31495302
doi: 10.1161/JAHA.119.012282
pmc: PMC6818015
doi:
Substances chimiques
Adrenergic beta-Antagonists
0
Angiotensin Receptor Antagonists
0
Angiotensin-Converting Enzyme Inhibitors
0
Mineralocorticoid Receptor Antagonists
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e012282Références
BMJ. 2014 May 05;348:g3072
pubmed: 24803082
J Am Heart Assoc. 2017 Nov 29;6(12):
pubmed: 29187385
Chest. 1999 Aug;116(2):346-54
pubmed: 10453861
Clin Cardiol. 2017 Feb;40(2):109-119
pubmed: 27862089
JAMA Intern Med. 2015 Jun;175(6):996-1004
pubmed: 25895156
Circ Heart Fail. 2013 Sep 1;6(5):890-7
pubmed: 23926203
Lancet. 2018 Feb 10;391(10120):572-580
pubmed: 29174292
Stroke. 2005 Sep;36(9):1984-7
pubmed: 16081854
J Am Coll Cardiol. 2013 Mar 26;61(12):1259-67
pubmed: 23500328
Circ J. 2016 Oct 25;80(11):2327-2335
pubmed: 27725417
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
N Engl J Med. 2010 Mar 25;362(12):1110-8
pubmed: 20335587
Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):407-13
pubmed: 20031870
Int Heart J. 2005 Sep;46(5):855-66
pubmed: 16272776
Circulation. 2018 Sep 4;138(10):965-967
pubmed: 30354536
Vasc Health Risk Manag. 2008;4(1):103-13
pubmed: 18629369
BMJ Open. 2014 Dec 30;4(12):e005988
pubmed: 25550294
Eur Heart J. 2008 Oct;29(19):2388-442
pubmed: 18799522
J Am Heart Assoc. 2019 Sep 17;8(18):e012282
pubmed: 31495302
Circulation. 2017 Aug 8;136(6):e137-e161
pubmed: 28455343